These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
464 related articles for article (PubMed ID: 19176965)
1. Efficacy and safety of levetiracetam (3,000 mg/Day) as an adjunctive therapy in Chinese patients with refractory partial seizures. Xiao Z; Li JM; Wang XF; Xiao F; Xi ZQ; Lv Y; Sun HB Eur Neurol; 2009; 61(4):233-9. PubMed ID: 19176965 [TBL] [Abstract][Full Text] [Related]
2. Multicenter double-blind, randomized, placebo-controlled trial of levetiracetam as add-on therapy in Chinese patients with refractory partial-onset seizures. Wu XY; Hong Z; Wu X; Wu LW; Wang XF; Zhou D; Zhao ZX; Lv CZ Epilepsia; 2009 Mar; 50(3):398-405. PubMed ID: 18657175 [TBL] [Abstract][Full Text] [Related]
3. Once-daily extended-release levetiracetam as adjunctive treatment of partial-onset seizures in patients with epilepsy: a double-blind, randomized, placebo-controlled trial. Peltola J; Coetzee C; Jiménez F; Litovchenko T; Ramaratnam S; Zaslavaskiy L; Lu ZS; Sykes DM; Epilepsia; 2009 Mar; 50(3):406-14. PubMed ID: 19317886 [TBL] [Abstract][Full Text] [Related]
4. The SKATE study: an open-label community-based study of levetiracetam as add-on therapy for adults with uncontrolled partial epilepsy. Steinhoff BJ; Somerville ER; Van Paesschen W; Ryvlin P; Schelstraete I Epilepsy Res; 2007 Aug; 76(1):6-14. PubMed ID: 17681453 [TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of levetiracetam 1000-3000 mg/day in patients with refractory partial-onset seizures: a multicenter, open-label single-arm study. Beran RG; Berkovic SF; Black AB; Danta G; Hiersemenzel R; Schapel GJ; Vajda FJ Epilepsy Res; 2005 Jan; 63(1):1-9. PubMed ID: 15716083 [TBL] [Abstract][Full Text] [Related]
6. Double-blind placebo-controlled trial of adjunctive levetiracetam in pediatric partial seizures. Glauser TA; Ayala R; Elterman RD; Mitchell WG; Van Orman CB; Gauer LJ; Lu Z; Neurology; 2006 Jun; 66(11):1654-60. PubMed ID: 16641323 [TBL] [Abstract][Full Text] [Related]
7. Adjunctive levetiracetam in infants and young children with refractory partial-onset seizures. Piña-Garza JE; Nordli DR; Rating D; Yang H; Schiemann-Delgado J; Duncan B; Epilepsia; 2009 May; 50(5):1141-9. PubMed ID: 19243423 [TBL] [Abstract][Full Text] [Related]
8. Dose-dependent safety and efficacy of zonisamide: a randomized, double-blind, placebo-controlled study in patients with refractory partial seizures. Brodie MJ; Duncan R; Vespignani H; Solyom A; Bitenskyy V; Lucas C Epilepsia; 2005 Jan; 46(1):31-41. PubMed ID: 15660766 [TBL] [Abstract][Full Text] [Related]
9. Levetiracetam extended release and levetiracetam immediate release as adjunctive treatment for partial-onset seizures: an indirect comparison of treatment-emergent adverse events using meta-analytic techniques. Richy FF; Banerjee S; Brabant Y; Helmers S Epilepsy Behav; 2009 Oct; 16(2):240-5. PubMed ID: 19699156 [TBL] [Abstract][Full Text] [Related]
10. Neurocognitive effects of adjunctive levetiracetam in children with partial-onset seizures: a randomized, double-blind, placebo-controlled, noninferiority trial. Levisohn PM; Mintz M; Hunter SJ; Yang H; Jones J; Epilepsia; 2009 Nov; 50(11):2377-89. PubMed ID: 19702752 [TBL] [Abstract][Full Text] [Related]
11. Efficacy of levetiracetam: a review of three pivotal clinical trials. Privitera M Epilepsia; 2001; 42 Suppl 4():31-5. PubMed ID: 11564123 [TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of 800 and 1200 mg eslicarbazepine acetate as adjunctive treatment in adults with refractory partial-onset seizures. Gil-Nagel A; Lopes-Lima J; Almeida L; Maia J; Soares-da-Silva P; Acta Neurol Scand; 2009 Nov; 120(5):281-7. PubMed ID: 19832771 [TBL] [Abstract][Full Text] [Related]
13. Eslicarbazepine acetate as adjunctive therapy in adult patients with partial epilepsy. Ben-Menachem E; Gabbai AA; Hufnagel A; Maia J; Almeida L; Soares-da-Silva P Epilepsy Res; 2010 May; 89(2-3):278-85. PubMed ID: 20299189 [TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of levetiracetam (up to 2000 mg/day) in Taiwanese patients with refractory partial seizures: a multicenter, randomized, double-blind, placebo-controlled study. Tsai JJ; Yen DJ; Hsih MS; Chen SS; Hiersemenzel R; Edrich P; Lai CW Epilepsia; 2006 Jan; 47(1):72-81. PubMed ID: 16417534 [TBL] [Abstract][Full Text] [Related]
15. Add-on levetiracetam in children and adolescents with refractory epilepsy: results of an open-label multi-centre study. Callenbach PM; Arts WF; ten Houten R; Augustijn P; Gunning WB; Peeters EA; Weber AM; Stroink H; Geerts Y; Geerts AT; Brouwer OF Eur J Paediatr Neurol; 2008 Jul; 12(4):321-7. PubMed ID: 17950011 [TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of eslicarbazepine acetate as adjunctive treatment in adults with refractory partial-onset seizures: a randomized, double-blind, placebo-controlled, parallel-group phase III study. Elger C; Halász P; Maia J; Almeida L; Soares-da-Silva P; Epilepsia; 2009 Mar; 50(3):454-63. PubMed ID: 19243424 [TBL] [Abstract][Full Text] [Related]
17. Rufinamide for the adjunctive treatment of partial seizures in adults and adolescents: a randomized placebo-controlled trial. Brodie MJ; Rosenfeld WE; Vazquez B; Sachdeo R; Perdomo C; Mann A; Arroyo S Epilepsia; 2009 Aug; 50(8):1899-909. PubMed ID: 19490053 [TBL] [Abstract][Full Text] [Related]
18. Adjunctive lacosamide for partial-onset seizures: Efficacy and safety results from a randomized controlled trial. Halász P; Kälviäinen R; Mazurkiewicz-Beldzińska M; Rosenow F; Doty P; Hebert D; Sullivan T; Epilepsia; 2009 Mar; 50(3):443-53. PubMed ID: 19183227 [TBL] [Abstract][Full Text] [Related]
19. Use of levetiracetam in hospitalized patients. Falip M; Carreño M; Amaro S; Donaire A; Delgado R; Toledo M; Maestro I Epilepsia; 2006 Dec; 47(12):2186-8. PubMed ID: 17201722 [TBL] [Abstract][Full Text] [Related]